AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10700663 — intervention group
Group type: EXPERIMENTAL
Intervention: other measures of REM sleep
Number of subjects: 14
Study 8777883 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 170
Study 8777883 — intervention group
Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 170
Study 1988669 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg 3 times daily)
Number of subjects: 8
Study 1988669 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 6802235 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative isotope liver scan
Number of subjects: 43
Study 6802235 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative ultrasonography
Number of subjects: 43
Study 6802235 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative computed tomography
Number of subjects: 43
Study 31494096 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg AMG 714
Number of subjects: 64
Study 31494096 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg AMG 714
Number of subjects: 64
Study 31494096 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 28735698 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood ADHD symptoms, IQ, and household income levels
Number of subjects: 837
Study 28735698 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood demographic, clinical, and family factors
Number of subjects: 837
Study 28735698 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline ADHD severity, IQ, comorbidity, family income, number of household members, parental education, parental monitoring, parental marital problems
Number of subjects: 837
Study 28735698 — intervention group
Group type: EXPERIMENTAL
Intervention: Timely treatments for ADHD symptoms and additional support for children with lower IQ and from low-income households
Number of subjects: 837
Study 25245863 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscope
Number of subjects: 0
Study 25245863 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnifying glasses
Number of subjects: 0
Study 25245863 — intervention group
Group type: COMPARATOR
Intervention: Unsupported vision
Number of subjects: 0
Study 23770889 — intervention group
Group type: EXPERIMENTAL
Intervention: Trampoline exercise intervention (daily individualized 20-min sessions for 12 weeks)
Number of subjects: 18
Study 23770889 — intervention group
Group type: COMPARATOR
Intervention: Regular school schedule (control group)
Number of subjects: 18
Study 21794162 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-test counseling by trained counselors and monthly home visits by community support agents
Number of subjects: 400
Study 21794162 — intervention group
Group type: COMPARATOR
Intervention: Standard care (existing post-test counseling by ARV clinic staff who lack basic training in counseling skills)
Number of subjects: 400
Study 18464801 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspheric lenses (Tecnis, Cee-on Edge, Acrysof Natural, IQ)
Number of subjects: 30
Study 18464801 — intervention group
Group type: COMPARATOR
Intervention: Tecnis lens
Number of subjects: 30
Study 18464801 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspheric lenses
Number of subjects: 30
Study 17520385 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic abdominoperineal resection
Number of subjects: 74
Study 17520385 — intervention group
Group type: COMPARATOR
Intervention: Open abdominoperineal resection
Number of subjects: 74
Study 17520385 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 74
Study 15215792 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan and Ramipril combination
Number of subjects: 25620
Study 15215792 — intervention group
Group type: COMPARATOR
Intervention: Telmisartan
Number of subjects: 25620
Study 11239640 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra-amniotic infusion of PGE2 (0.5 microg/mL)
Number of subjects: 116
Study 11239640 — intervention group
Group type: COMPARATOR
Intervention: Extra-amniotic infusion of saline
Number of subjects: 116
Study 9569440 — intervention group
Group type: EXPERIMENTAL
Intervention: Septorhinoplasty patients
Number of subjects: 25
Study 9569440 — intervention group
Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 25
Study 8072387 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded doses of licorice (814 mg glycyrrhizin)
Number of subjects: 24
Study 8072387 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded doses of licorice (380 mg glycyrrhizin)
Number of subjects: 24
Study 8072387 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded doses of licorice (217 mg glycyrrhizin)
Number of subjects: 24
Study 8072387 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded doses of licorice (108 mg glycyrrhizin)
Number of subjects: 24
Study 8072387 — intervention group
Group type: COMPARATOR
Intervention: Control group (no licorice)
Number of subjects: 24
Study 2468871 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine (5-20 mg b.i.d.)
Number of subjects: 274
Study 2468871 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (40-120 mg b.i.d.)
Number of subjects: 274
Study 2468871 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 274
Study 2468871 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 274
Study 31050048 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitions to failure (RFG)
Number of subjects: 36
Study 31050048 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitions not to failure (NFG)
Number of subjects: 36
Study 31050048 — intervention group
Group type: EXPERIMENTAL
Intervention: Equal training volume not to failure (ENFG)
Number of subjects: 36
Study 31050048 — intervention group
Group type: COMPARATOR
Intervention: All groups (RFG, NFG, ENFG)
Number of subjects: 36
Study 27639785 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized multi-condition risk assessment (HRA)
Number of subjects: 3703
Study 27639785 — intervention group
Group type: COMPARATOR
Intervention: Control group (risk perception assessment only)
Number of subjects: 3703
Study 26385046 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (12-week standardized aerobic exercise program)
Number of subjects: 93
Study 26385046 — intervention group
Group type: COMPARATOR
Intervention: Control group (lifestyle as usual)
Number of subjects: 93
Study 23336506 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi exercise (one hour every two days)
Number of subjects: 70
Study 23336506 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Tai Chi exercise)
Number of subjects: 70
Study 23336506 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi exercise
Number of subjects: 70
Study 22040504 — intervention group
Group type: EXPERIMENTAL
Intervention: Lianhuaqingwen capsule (LHC)
Number of subjects: 244
Study 22040504 — intervention group
Group type: COMPARATOR
Intervention: Oseltamivir
Number of subjects: 244
Study 19453758 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin (140 mg three times a day) plus desferrioxamine
Number of subjects: 59
Study 19453758 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus desferrioxamine
Number of subjects: 59
Study 16405436 — intervention group
Group type: EXPERIMENTAL
Intervention: DTPA clearance using 35 mCi (1295 MBq) of Tc 99m-DTPA
Number of subjects: 43
Study 16405436 — intervention group
Group type: EXPERIMENTAL
Intervention: DTPA clearance
Number of subjects: 43
Study 15175216 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper clip set
Number of subjects: 75
Study 15175216 — intervention group
Group type: COMPARATOR
Intervention: Disk-Criminator
Number of subjects: 75
Study 11471852 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril 5 ‐ 10 mg/day
Number of subjects: 320
Study 11471852 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine SR 20 ‐ 40 mg twice daily
Number of subjects: 320
Study 11471852 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril
Number of subjects: 320
Study 11471852 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine SR
Number of subjects: 320
Study 9627123 — intervention group
Group type: COMPARATOR
Intervention: HLA allele DQB1*0302
Number of subjects: 46
Study 9627123 — intervention group
Group type: COMPARATOR
Intervention: HLA allele DQB1*0402
Number of subjects: 46
Study 8161627 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunneled catheters (TCs)
Number of subjects: 169
Study 8161627 — intervention group
Group type: COMPARATOR
Intervention: Nontunneled catheters (NTCs)
Number of subjects: 169
Study 3348161 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ferrous sulfate.kg‐1.d‐1 for 12 weeks
Number of subjects: 119
Study 3348161 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 12 weeks
Number of subjects: 119
Study 28809582 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol 270
Number of subjects: 306
Study 28809582 — intervention group
Group type: COMPARATOR
Intervention: Iopromide 300
Number of subjects: 306
Study 28566173 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (14,000 IU/day)
Number of subjects: 40
Study 28566173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 28566173 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 40
Study 26232348 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine (IIV)
Number of subjects: 166
Study 26232348 — intervention group
Group type: COMPARATOR
Intervention: Live attenuated influenza vaccine (LAIV)
Number of subjects: 166
Study 26232348 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined (IIV and LAIV)
Number of subjects: 166
Study 23820968 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided adductor canal block with 0.5% ropivacaine
Number of subjects: 50
Study 23820968 — intervention group
Group type: COMPARATOR
Intervention: Sham subcutaneous injection of sterile saline
Number of subjects: 50
Study 20956393 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg
Number of subjects: 87
Study 20956393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 18494215 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular moderate-intensity exercise training
Number of subjects: 60
Study 18494215 — intervention group
Group type: COMPARATOR
Intervention: Standard measures (Control)
Number of subjects: 60
Study 17058517 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg once daily (n = 90)
Number of subjects: 180
Study 17058517 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole 40 mg once daily (n = 90)
Number of subjects: 180
Study 12560228 — intervention group
Group type: EXPERIMENTAL
Intervention: Left-sided CVL
Number of subjects: 85
Study 12560228 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclavian CVL
Number of subjects: 85
Study 12560228 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous CVL insertion
Number of subjects: 85
Study 12560228 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclavian vein CVL inserted percutaneously
Number of subjects: 85
Study 12560228 — intervention group
Group type: COMPARATOR
Intervention: CVL placement on the right side and in the jugular vein
Number of subjects: 85
Study 12560228 — intervention group
Group type: COMPARATOR
Intervention: Subclavian vein placement with venous cut-down
Number of subjects: 85
Study 11816746 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological factors (depression, anxiety, type A behavior)
Number of subjects: 0
Study 9716056 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin suspension (10 mg/kg every 12 h for 5 days, maximum individual dose 500 mg)
Number of subjects: 120
Study 9716056 — intervention group
Group type: COMPARATOR
Intervention: Pivmecillinam tablets (15-20 mg/kg every 8 h for 5 days, maximum individual dose 300 mg)
Number of subjects: 120
Study 9716056 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin suspension
Number of subjects: 120
Study 9716056 — intervention group
Group type: COMPARATOR
Intervention: Pivmecillinam tablets
Number of subjects: 120
Study 7979041 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflated tissue expanders
Number of subjects: 50
Study 7979041 — intervention group
Group type: EXPERIMENTAL
Intervention: Deflated tissue expanders
Number of subjects: 50
Study 7979041 — intervention group
Group type: COMPARATOR
Intervention: Displaced view with inflated implants
Number of subjects: 50
Study 7979041 — intervention group
Group type: EXPERIMENTAL
Intervention: Deflated adjustable implants
Number of subjects: 50
Study 2722728 — intervention group
Group type: EXPERIMENTAL
Intervention: cefoxitin sodium (30 mg/kg)
Number of subjects: 30
Study 2722728 — intervention group
Group type: EXPERIMENTAL
Intervention: cefmetazole sodium (15 mg/kg)
Number of subjects: 30
Study 2722728 — intervention group
Group type: EXPERIMENTAL
Intervention: cefmetazole sodium (30 mg/kg)
Number of subjects: 30
Study 48347 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone 1 mg
Number of subjects: 143
Study 48347 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone 2 mg
Number of subjects: 143
Study 48347 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone 0.5 mg
Number of subjects: 143
Study 48347 — intervention group
Group type: COMPARATOR
Intervention: Morphine 5 mg
Number of subjects: 143
Study 48347 — intervention group
Group type: COMPARATOR
Intervention: Morphine 10 mg
Number of subjects: 143
Study 31307524 — intervention group
Group type: EXPERIMENTAL
Intervention: UGSJB granule with acupuncture, twice daily
Number of subjects: 240
Study 31307524 — intervention group
Group type: COMPARATOR
Intervention: Placebo with acupuncture, twice daily
Number of subjects: 240
Study 28372556 — intervention group
Group type: EXPERIMENTAL
Intervention: Central Concentrate System (CCS)
Number of subjects: 16
Study 28372556 — intervention group
Group type: COMPARATOR
Intervention: Pre-produced bicarbonate concentrates (PPC)
Number of subjects: 16
Study 26135463 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion (cIV) of 160 mg furosemide for 16 h/day (n=15)
Number of subjects: 43
Study 26135463 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus injections (bI) of 80 mg furosemide twice a day (n=14)
Number of subjects: 43
Study 26135463 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide plus hypertonic saline solution (HSS) as an infusion for 30 min once a day (n=14)
Number of subjects: 43
Study 23066720 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (0.4 mg/kg weekly)
Number of subjects: 111
Study 23066720 — intervention group
Group type: COMPARATOR
Intervention: Acitretin (0.5 mg/kg daily)
Number of subjects: 111
Study 21247300 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive model for advance care planning discussions implemented in a quality improvement project
Number of subjects: 0
Study 18451394 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncovered trays in room with traffic
Number of subjects: 45
Study 18451394 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncovered trays in room without traffic
Number of subjects: 45
Study 18451394 — intervention group
Group type: EXPERIMENTAL
Intervention: Covered trays with sterile towel
Number of subjects: 45
Study 16601628 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based intervention to improve behavioral symptoms and caregiver self-efficacy
Number of subjects: 42
Study 12951131 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct training with stimuli (dictated words, pictures, printed words)
Number of subjects: 0
Study 12951131 — intervention group
Group type: COMPARATOR
Intervention: Observing a model without disabilities demonstrating conditional discriminations
Number of subjects: 0
Study 12951131 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct training with stimuli in three sets
Number of subjects: 0
Study 12951131 — intervention group
Group type: COMPARATOR
Intervention: Observing a model's training with stimuli in three different sets
Number of subjects: 0
Study 10855154 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based preoperative bowel preparation with home care services
Number of subjects: 0
Study 10855154 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based preoperative bowel preparation without home care services
Number of subjects: 0
Study 10855154 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based preoperative bowel preparation
Number of subjects: 0
Study 9096986 — intervention group
Group type: EXPERIMENTAL
Intervention: Glipizide GITS (5, 20, 40, or 60 mg)
Number of subjects: 347
Study 9096986 — intervention group
Group type: EXPERIMENTAL
Intervention: Glipizide GITS (5, 10, 15, or 20 mg)
Number of subjects: 347
Study 9096986 — intervention group
Group type: EXPERIMENTAL
Intervention: Glipizide GITS
Number of subjects: 347
Study 9096986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 347
Study 8467308 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured treatment and teaching programme (4 group sessions conducted by paramedical personnel)
Number of subjects: 100
Study 8467308 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued hypertension care without the structured programme)
Number of subjects: 100
Study 8467308 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured treatment and teaching programme
Number of subjects: 100
Study 8467308 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 30882137 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course therapy (median, 9 days; IQR, 8-10)
Number of subjects: 249
Study 30882137 — intervention group
Group type: COMPARATOR
Intervention: Long-course therapy (median, 16 days; IQR, 14-17)
Number of subjects: 249
Study 28959909 — intervention group
Group type: EXPERIMENTAL
Intervention: Whitening toothpaste (specific kind not mentioned)
Number of subjects: 60
Study 28959909 — intervention group
Group type: COMPARATOR
Intervention: Conventional non-whitening toothpaste
Number of subjects: 60
Study 25698156 — intervention group
Group type: EXPERIMENTAL
Intervention: Open arch surgery
Number of subjects: 46
Study 25698156 — intervention group
Group type: COMPARATOR
Intervention: Hybrid arch procedure
Number of subjects: 46
Study 24447425 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegloticase 8 mg every 2 weeks
Number of subjects: 103
Study 24447425 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegloticase 8 mg every 4 weeks
Number of subjects: 103
Study 24447425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 24447425 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegloticase (both dosing cohorts)
Number of subjects: 103
Study 22791906 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cannabis extract (CE) 25 mg daily after titration
Number of subjects: 279
Study 22791906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 279
Study 20436237 — intervention group
Group type: EXPERIMENTAL
Intervention: Active LLLT (cluster probe with 5 laser diodes; lambda = 810 nm; 200 mW power output; 30 seconds of irradiation, applied in 2 locations over the biceps of the nondominant arm; 60 J of total energy)
Number of subjects: 9
Study 20436237 — intervention group
Group type: EXPERIMENTAL
Intervention: Active LLLT
Number of subjects: 9
Study 20436237 — intervention group
Group type: COMPARATOR
Intervention: Placebo LLLT
Number of subjects: 9
Study 16981900 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg montelukast daily for 6 days
Number of subjects: 10
Study 16049631 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment and counseling with a self-help guide for 7 weeks
Number of subjects: 300
Study 11801262 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week relaxation program
Number of subjects: 26
Study 11801262 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (TCs, n=18)
Number of subjects: 26
Study 11801262 — intervention group
Group type: COMPARATOR
Intervention: Non-tinnitus participants (NTPs, n=13)
Number of subjects: 26
Study 10071523 — intervention group
Group type: EXPERIMENTAL
Intervention: NADH (10 mg)
Number of subjects: 26
Study 10071523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 7730525 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity (HI) training group
Number of subjects: 36
Study 7730525 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity (LO) training group
Number of subjects: 36
Study 7730525 — intervention group
Group type: COMPARATOR
Intervention: Control (CO) group
Number of subjects: 36
Study 1787697 — intervention group
Group type: EXPERIMENTAL
Intervention: Keep A Clear Mind (KACM) program
Number of subjects: 511
Study 1787697 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 511
Study 7174213 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital treatment with short-wave diathermy and daily exercises with graduated weights
Number of subjects: 0
Study 7174213 — intervention group
Group type: COMPARATOR
Intervention: Home exercises with graduated weights
Number of subjects: 0
Study 31084316 — intervention group
Group type: EXPERIMENTAL
Intervention: Children’s Heart Assessment Tool for Transplantation (CHAT) Score
Number of subjects: 5700
Study 27906448 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent, targeted, low-literacy educational intervention (targeted photonovella booklet/DVD plus FIT kit)
Number of subjects: 416
Study 27906448 — intervention group
Group type: COMPARATOR
Intervention: Standard, nontargeted educational intervention (standard CDC brochure plus FIT kit)
Number of subjects: 416
Study 27906448 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 416
Study 27906448 — intervention group
Group type: EXPERIMENTAL
Intervention: Health insurance status
Number of subjects: 416
Study 26519106 — intervention group
Group type: EXPERIMENTAL
Intervention: STAR training portal (experimental group)
Number of subjects: 142
Study 26519106 — intervention group
Group type: COMPARATOR
Intervention: Control group (received access to STAR after the research)
Number of subjects: 142
Study 28166025 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based workshop
Number of subjects: 27
Study 28166025 — intervention group
Group type: COMPARATOR
Intervention: Traditional case-based workshop
Number of subjects: 27
Study 28166025 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 27
Study 21897852 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 210